Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$83.89 USD
+0.84 (1.01%)
Updated Sep 18, 2024 03:59 PM ET
After-Market: $83.90 +0.01 (0.01%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Brokerage Reports
Gilead Sciences, Inc. [GILD]
Reports for Purchase
Showing records 1 - 20 ( 534 total )
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 091624
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Hepatitis B Breakthrough Boom: Navigating a $450-$500 Billion Frontier
Provider: H.C. Wainwright & Co., Inc.
Analyst: TRUCCHIO P
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 21124
Provider: Stock Traders Daily
Analyst: Research Department
Company: Gilead Sciences, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for GILD 12124
Provider: Stock Traders Daily
Analyst: Research Department